Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 14 Dec 2021 for Reneo Pharmaceuticals, Inc.. Read the official filing
Filing timeline
BuySaleGregory J. Flesher
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Gregory J. Flesher: trading record in brief
Gregory J. Flesher (chief executive) discloses dealings in OnKure Therapeutics, Inc. to SEC (Form 4). Between 25 August 2021 and 10 December 2021, the trades on record add up to 2 filings.
No open-market sale appears; the market trades are 1 purchase worth €54k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant.
The record was last updated on 14 December 2021 with a share grant in OnKure Therapeutics, Inc. The latest purchase dates back some time: it was published 1,879 days ago, on 26 August 2021. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Gregory J. Flesher
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
100,000 shares0Common StockSEC:0001209191-21-069443:0
8,000 shares@ US$8.00100.0% of flowCommon StockSEC:0001209191-21-053522:0
Canonical exit: 23 Nov 2021 (T+90)
2 of 2 declarations
